EGR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.443200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.763200E-01
Normal-vs-Stage2
9.190200E-01
Normal-vs-Stage3
7.252600E-01
Normal-vs-Stage4
4.068000E-01
Stage1-vs-Stage2
6.869800E-01
Stage1-vs-Stage3
7.979800E-01
Stage1-vs-Stage4
2.212800E-01
Stage2-vs-Stage3
5.367600E-02
Stage2-vs-Stage4
7.019500E-02
Stage3-vs-Stage4
2.518200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.447600E-01
Normal-vs-AfricanAmerican
7.292600E-01
Normal-vs-Asian
6.525000E-01
Caucasian-vs-AfricanAmerican
6.424800E-01
Caucasian-vs-Asian
3.527200E-01
AfricanAmerican-vs-Asian
2.785400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.829200E-01
Normal-vs-Female
8.915400E-01
Male-vs-Female
6.711400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.755400E-01
Normal-vs-Age(41-60Yrs)
6.785200E-01
Normal-vs-Age(61-80Yrs)
9.362800E-01
Normal-vs-Age(81-100Yrs)
4.671600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.330200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.416600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.339800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.368200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.621970E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.923400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.049600E-01
Normal-vs-Daily Drinker
4.652600E-01
Normal-vs-Weekly Drinker
8.590000E-01
Normal-vs-Occasional Drinker
6.493800E-01
Normal-vs-Social Drinker
9.001000E-01
Non Drinker-vs-Daily Drinker
1.285420E-01
Non Drinker-vs-Weekly Drinker
9.493000E-01
Non Drinker-vs-Occasional Drinker
2.897000E-01
Non Drinker-vs-Social Drinker
9.515400E-01
Daily Drinker-vs-Weekly Drinker
1.175360E-01
Daily Drinker-vs-Occasional Drinker
5.871600E-01
Daily Drinker-vs-Social Drinker
2.865800E-01
Weekly Drinker-vs-Occasional Drinker
2.784600E-01
Weekly Drinker-vs-Social Drinker
9.974600E-01
Occasional Drinker-vs-Social Drinker
4.385400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.744200E-01
Normal-vs-Grade 2
3.026200E-01
Normal-vs-Grade 3
3.044800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.170500E-02
Grade 1-vs-Grade 3
4.028100E-02
Grade 1-vs-Grade 4
6.744200E-01
Grade 2-vs-Grade 3
5.073800E-01
Grade 2-vs-Grade 4
3.026200E-01
Grade 3-vs-Grade 4
3.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.979800E-01
Normal-vs-NonDiabetic
9.341400E-01
Diabetic-vs-NonDiabetic
7.968000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.422200E-01
Normal-vs-NoPancreatitis
9.997600E-01
Pancreatitis-vs-NoPancreatitis
1.719180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.723000E-01
Normal-vs-N1
9.074600E-01
N0-vs-N1
7.837200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.583960E-01
Normal-vs-TP53-NonMutant
3.591400E-01
TP53-Mutant-vs-TP53-NonMutant
4.021800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
